We are happy to have an article, ‘The emergence of RWD and RWE – are they an alternative to RCT?’ published in Express Pharma magazine.

Authored by Venkatesan Balu, Associate Director of Global Data Science, Navitas Life Sciences, the article explores the accumulating evidence from real-world data (RWD) and advances in technology that suggest that hybrid clinical studies that utilize RWD have the potential to support regulatory decisions in the absence of randomized controlled trial (RCT) data.

Please complete the form to download the article.

Published by Express Pharma
 April 2023 | Volume 18, No. 5 | Pages 25 - 27

© 2023 Navitas Life Sciences | Privacy Policy